Loading clinical trials...
Loading clinical trials...
A Single-Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of SUBLOCADE at Alternative Injection Locations in Adults
Conditions
Interventions
Buprenorphine Extended-Release Injection
Locations
6
United States
Artemis Institute for Clinical Research
San Diego, California, United States
Research Centers of America
Hollywood, Florida, United States
Miami Lakes Medical Research
Miami Lakes, Florida, United States
Rivus Wellness and Research Institute
Oklahoma City, Oklahoma, United States
InSite Clinical Research, LLC
DeSoto, Texas, United States
Pillar Clinical Research, LLC
Richardson, Texas, United States
Start Date
March 1, 2023
Primary Completion Date
November 1, 2023
Completion Date
November 1, 2023
Last Updated
January 7, 2025
NCT06651177
NCT06843213
NCT05995886
NCT07044466
NCT07350148
NCT06585709
Lead Sponsor
Indivior Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions